Deep Track Capital, LP 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-02-14 08:43 am Sale |
2023-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX |
Deep Track Capital, LP | 2,537,176 4.000% |
-837,218![]() (-24.81%) |
Filing |
2022-09-23 4:11 pm Purchase |
2022-09-14 | 13G | Edgewise Therapeutics, Inc. EWTX |
Deep Track Capital, LP | 3,374,394 5.340% |
3,374,394![]() (New Position) |
Filing |